Skip to content

Clinical study for the new severity stage of idiopathic pulmonary fibrosis

Clinical study for the new severity stage of idiopathic pulmonary fibrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-17010683
Enrollment
Unknown
Registered
2017-02-20
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial lung disease

Interventions

Case series:Nil

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Idiopathic pulmonary fibrosis (IPF) patients diagnosed according to the 2013 ATS/ERS/JRS/ALAT and Connective tissue disease associated interstitial lung disease patients diagnosed according to 2015 ERS/ATS; 2. Male or female aged 40 to 80 years old; 3. Have good compliance; 4. Patients were fully informed of the purpose method and possible discomfort of the test, agree and signed in consent.

Exclusion criteria

Exclusion criteria: 1. With lung infections need antibiotic treatment (Respiratory infection or systemic infection within four weeks); 2. Having malignant tumor; 3. Having serious diseases in other system and organ dysfunction; 4. There is any unsuitable situation for those selected.

Design outcomes

Primary

MeasureTime frame
High-resolution chest CT;Lung function;Chest radiography;6-minute walk test;SGRQ;

Countries

China

Contacts

Public ContactLi Huiping

Shanghai Pulmonary Hospital Tongji University, School of Medicine

liw2013@126.com+86 13817389991

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026